Business
Issuance of Notes
Issuance of Notes.
About this update from Gsk Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 6780F\n GlaxoSmithKline PLC\n 23 March 2022\n \n \n \n \n GlaxoSmithKline plc \n \n \n Issued: 23 March 2022, London UK\n \n \n \n \n \n \n \n \n \n \n \n ISSUANCE OF NOTES\n \n \n \n \n \n GSK Consumer Healthcare Capital UK plc and GSK Consumer Healthcare Capital NL B.V. (together with GSK Consumer Healthcare Capital UK plc, the \"EMTN Issuers\") announce that, on 22 March 2022, they successfully priced the following notes (the \"EMTNNotes\") under the GBP 10,000,000,000 Euro Medium Term Note Programme of the EMTN Issuers:\n \n \n - GBP 300,000,000 2.875% Fixed Rate Senior Notes due 2028 and GBP 400,000,000 3.375% Fixed Rate Senior Notes due 2038, each issued by GSK Consumer Healthcare Capital UK plc; and\n \n \n \n \n \n - EUR 850,000,000 1.250% Fixed Rate Notes due 2026, EUR 750,000,000 1.750% Fixed Rate Senior Notes due 2030 and EUR 750,000,000 2.125% Fixed Rate Senior Notes due 2034, each issued by GSK Consumer Healthcare Capital NL B.V.\n \n \n \n \n \n In addition, \n GSK Consumer Healthcare Capital UK plc and GSK Consumer Healthcare Capital US LLC announce that, on 21 March 2022, they successfully priced the following notes (the \"144A Notes\") pursuant to an Offering Memorandum dated 21 March 2022:\n \n \n \n \n \n - USD 700,000,000 3.024% Callable Fixed Rate Senior Notes due 2024, USD 300,000,000 Callable Floating Rate Senior Notes due 2024, USD 2,000,000,000 3.375% Fixed Rate Senior Notes due 2027, USD 1,000,000,000 3.375% Fixed Rate Senior Notes due 2029, USD 2,000,000,000 3.625% Fixed Rate Senior Notes due 2032 and USD 1,000,000,000 4.000% Fixed Rate Senior Notes due 2052, each issued by GSK Consumer Healthcare Capital US LLC; and\n \n \n \n \n \n - USD 1,750,000,000 3.125% Fixed Rate Senior Notes due 2025 issued by GSK Consumer Healthcare Capital UK plc.\n \n \n The EMTN Notes and the 144A Notes (together, the \"Notes\") will be guaranteed by GlaxoSmithKline plc up to and excluding the Guarantee Assumption Date (as defined in the Terms and Conditions of the Notes).\n \n \n \n \n \n For further information, please contact:\n \n \n GlaxoSmithKline plc\n980 Great West Road\nBrentford\nMiddlesex\nTW8 9GS\nUnited Kingdom\n \n \n \n \n \n \n UK Media enquiries:\n \n \n \n \n David Mawdsley Simon Steel \n \n ...